Podcast Episodes
Back to SearchBiotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil
Episode 320
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ven…
6 hours ago
Getting To A First Product Approval With Celcuity's Brian Sullivan
Episode 319
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks abou…
1 week ago
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
Episode 318
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Membe…
2 weeks ago
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
Episode 317
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children'…
3 weeks ago
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
Episode 316
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Ge…
4 weeks ago
Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.
Episode 315
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Bu…
1 month ago
BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin
Episode 314
We love to hear from our listeners. Send us a message.
On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, an…
1 month, 1 week ago
BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.
Episode 313
We love to hear from our listeners. Send us a message.
This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego…
1 month, 2 weeks ago
Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.
Episode 312
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Al Sandrock, M.D., Ph.D., President and CEO…
1 month, 3 weeks ago
Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho
Episode 311
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gam…
2 months ago